Home › Macular Degeneration › NCT06593405

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma

The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, Diabetic Retinopathy (DR) and Glaucoma

Who can join

Ages 50 to 100 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Clients with AMD, DR or Glaucoma
* Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.

Exclusion Criteria:

* Clients with other age related eye diseases other than AMD, DR or Glaucoma.
* Clients who do not wish to participate in this study.

About the study

The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are:

Does additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task?

Participants will:

Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.

What is being tested

• occupational therapy interventions for low vision care (combination product)

Sponsor: MCPHS University · Participants: 50 · Started: Apr 22, 2025

Contact the study team

• Michelle Dowling, OTD · Phone: 508-373-5851

Official record on ClinicalTrials.gov — NCT06593405

Locations in the U.S.

Conditions

• Macular Degeneration

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.